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tests. In practice, many labs perform the rapid and easy to perform EIA for toxin A and B detection, though this test lacks sensitivity and is considered a suboptimal approach by current clinical practice guidelines [6] . More recently, nucleic acid amplification tests including real-time PCR and LAMP have been developed for diagnosis of CDI. Some hospitals have already begun to implement these tests in order to improve the rapidity of CDI testing and detection rates. Two previous meta-analyses have evaluated at the diagnostic characteristics of real-time PCR. They found that while it is highly sensitive and specific, it is also dependent on CDI prevalence [7, 10] . While most commercially available real-time PCR assays are designed to detect a conservative region of tcdB, it has been reported that in C. difficile variant strains, tcdA is more conserved [11] . The Illumigene TM C. difficile Assay (Meridian Bioscience, Cincinnati, OH) uses loop-mediated isothermal amplification technology to detect a 204-bp sequence in the conserved 5' region of tcdA. While some variant C. difficile strains have deletions at the 3' end of the tcdA gene, the 5' portion remains intact for these strains [12] . A recent study confirmed the ability of the Illumigene assay to detect these Toxin A-/B+ strains [13] . The
Illumigene assay is currently the only commercial LAMP assay approved for U.S.
laboratory use. The FDA now requires all vendors to include toxigenic culture as a comparator for any new diagnostic test for C. difficile detection. One systematic review evaluated the diagnostic capabilities of LAMP for detection of CDI and concluded that LAMP was a promising test, but further investigation was necessary to evaluate LAMP as a diagnostic tool [7] . The most recent Infectious Diseases Society of America (IDSA)/Society for Healthcare of America (SHEA) guidelines on diagnostic testing of C.
difficile suggest that more data are needed on nucleic acid amplification tests before it
can be implemented for routine use [6] . We performed a meta-analysis to assess the capabilities of LAMP in the diagnosis of CDI. The aim of this study was to investigate whether LAMP is sensitive and specific enough for the diagnosis of CDI when used as a stand-alone test.
Methods
This review was performed with a standardized written protocol that followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement guidelines [14] .
Search Strategy
We systematically searched the literature using the following predetermined inclusion criteria. Studies evaluating LAMP as a diagnostic test for CDI were eligible for inclusion if the studies (1) described original research; (2) performed stool specimen analyses from inpatients or outpatients; (3) compared LAMP to a reference method -either CCNA or anaerobic TC; (4) reported total number of patients tested and positive/negative results that allow calculation of true positives (TP), true negatives (TN), false positives (FP), false negatives (FN); (5) In the excluded studies, LAMP tests were confirmed using other diagnostic tests but not A C C E P T E D M A N U S C R I P T P.) in order to choose potentially relevant articles, and disagreements about particular studies were discussed and resolved. When multiple articles for a single study had been published by the same authors, we used the most relevant publication and supplemented it, if necessary, with data from other publications. Authors of studies were contacted when the information was not available in the published study.
Data Extraction
Two investigators (A. L. and V. P.) independently extracted data from full text of the included studies, and disagreements were discussed and resolved. All studies evaluated the diagnostic accuracy of LAMP on a per-sample basis.
Assessment of Study Quality
The methodological quality for each paper was assessed independently by 2 investigators (A. L. and V. P.) using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) [15] criteria and disagreements were discussed and resolved.
Data Synthesis and Meta-Analysis
The TP, FP, TN, and FN were taken directly from the source papers. Where this information was not available, the values were calculated from the data that were provided in the article. In some cases the corresponding authors of the article were contacted to gather information for creating the 2 X 2 table. Data were analysed using the 'midas' and 'metandi' module for STATA (version 12) and two freeware programs i.e. Open Meta[analyst] (version 1.4) [16] and . To synthesize data, we employed a bivariate random-effects model. The bivariate model pairs sensitivity and specificity simultaneously for each study, accommodating their natural correlation, thus preserving the two-dimensional nature of the data and allows for negative correlation within studies [17] . Using a random-effects approach for both sensitivity and specificity the model also accounts for clinical and methodological heterogeneity between the studies [18] . We also calculated the positive likelihood ratio (PLR), negative likelihood ratio (NLR), and a hierarchical summary receiver-operating
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8 characteristics (HSROC) curve. To address 0 observations in 2 × 2 contingency tables, continuity correction was achieved by adding 0.5 to each cell. We calculated κ statistics to assess the agreement between the two investigators for study selection, data extraction and assessment of methodological quality.
Investigations of Heterogeneity
To assess heterogeneity, we calculated the inconsistency index, I
2 . An I 2 of 33-66% was considered as moderate heterogeneity. To address potential heterogeneity among studies, we performed subgroup analysis on pre-specified variable: the calculated prevalence of C. difficile (<15% and ≥15%). As different cut-offs or thresholds were not expected for the LAMP assay among the studies, we did not explore threshold effect as a potential source of heterogeneity.
Publication Bias
The presence and effect of publication bias were examined using Deeks' regression test of asymmetry [19] and Egger's test [20] .
Fagan's nomogram
The relationship between pre-test probability and post-test probability was depicted by visual Fagan's nomogram [21] . The pre-test and post-test probabilities are both subjective estimates of the presence of a disease before and after a diagnostic test.
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Results

Study Characteristics
Our search yielded 60 articles; 30 potentially relevant citations were selected based on relevance to the study topic. After reviewing the titles and abstracts, 21 articles were selected for full-text evaluation (Figure 1 ). Sixteen articles with 18 studies published between 2005 and 2014 reported the sensitivity and specificity of LAMP on stool samples for the diagnosis of C. difficile infection, and were included in our meta-analysis [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . Five articles were excluded (reasons for exclusion in Figure 1 ). The inter-rater reliability for study selection was 0.96. Table 1 summarizes the main study characteristics of the included studies. In total, 6,979 stool samples from patients at risk of CDI were included in the meta-analysis. The prevalence of CDI across all studies ranged from 10% to 60%. LAMP was used for diagnostic purposes in all the studies and not for screening patients. The quality of studies as assessed by the QUADAS-2 tool was generally high, with all but one study [35] meeting 6 or more of the criteria (Supplementary figure 1A and 1B) . Three studies [28, 36, 37] used CCNA as a reference test. In one study [28] , the investigators reported the diagnostic accuracy separately for both the reference standards. The inter-rater reliability for assessment of quality items was 0.88.
Meta-Analysis
Results are given as values (95% CI). With anaerobic TC as the reference test (15 studies, 6,572 samples) and using a bivariate random-effects model the results were as A C C E P T E D M A N U S C R I P T (Figure 3 ). There was substantial heterogeneity for all the statistical measures.
The statistically non-significant p-value for the slope co-efficient suggests symmetry in the data and a relative low likelihood of publication bias by Deeks' regression test of asymmetry (t= -1.56; p=0.14) (Figure 4) . The relationship between pre-test probability and post-test probability was depicted by visual Fagan's nomogram. For patients with a pre-test probability of 20%, the post-test probability of positive results was 95% and post-test probability of negative results was 1% ( Figure 5 ).
As there were less than 4 studies with CCNA as the reference standard, we could not undertake a bivariate analysis or fit a hierarchical model with all 5 parameters by maximum likelihood. Therefore, a separate univariate meta-analysis was performed.
With CCNA as the reference test (3 studies, 407 samples), the results were as follows: Publication bias was not evaluated as there were inadequate number of included studies (<10) to properly assess a funnel plot.
We explored the source of heterogeneity in terms of CDI prevalence and sample size.
Analysis stratified by region was unpractical because of ≤ 3 studies from each country.
A C C E P T E D M A N U S C R I P T Subgroup Analysis by CDI Prevalence
Using a bivariate random-effects model, at a prevalence of <15% (5 
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12 against increasing CDI prevalence. The PPV values correlated positively with increasing CDI prevalence, whereas NPV remained almost the same ( Figure 6 ).
In studies with anaerobic TC as the reference test, sensitivity analysis was also performed by omitting studies individually from the meta-analysis, and the pooled results of the remaining studies were largely the same (data not shown).
Discussion
The LAMP assay evaluated here, which amplifies the C. difficile tcdA gene, demonstrated high sensitivity and specificity in comparison to anaerobic TC as the reference standard for diagnosing CDI. Despite statistical heterogeneity, the diagnostic accuracy was consistently similar in the direction of effect in the majority of the studies.
The likelihood ratios for the LAMP assay indicate that the test is useful in determining post-test probability of CDI. Also, the PPV increases as the prevalence increases and reaches 95%, for a CDI prevalence of ≥15%.
The rising incidence and severity of CDI continues to be a major challenge for health-care institutions. A rapid, accurate diagnosis followed by prompt treatment are critical in the management of CDI and prevention of transmission [38, 39] . Barbut et al. found that a change from toxigenic culture and CTA to a NAAT or a 2-step algorithm including GDH and NAAT resulted in a significant reduction in the time to reporting of test results and earlier initiation of treatment, reduced empiric therapy in patients without CDI, and a decrease in processing of multiple samples. The authors concluded that
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13 reducing delays in testing may improve the quality of patient management [40] . Several recent studies have demonstrated that real-time PCR for toxin B gene has a high sensitivity and specificity in detecting CDI [7, 10] . In a recent diagnostic accuracy meta-analysis evaluating real-time PCR (toxin B gene) the pooled sensitivity and specificity were 92% and 94%, respectively. In contrast, our meta-analysis found a pooled sensitivity and specificity of LAMP to be 95% and 99% respectively. These data suggest that possibility that the LAMP assay may be more sensitive and specific than real-time PCR in detecting CDI. Also, the PPV and NPV for LAMP are better than realtime PCR in settings where CDI prevalence is <15% [7] . Therefore, real-time PCR may be more suitable in epidemic conditions with higher C. difficile prevalence and LAMP may be better in settings with lower C. difficile prevalence. In a previous systematic review of 6 studies published in 2012, O'Horo et al, evaluated the performance of LAMP in the detection of CDI [7] . They concluded that LAMP was a promising test and further investigation was necessary to evaluate LAMP as a diagnostic tool. Our systematic review identified several additional studies since the publication of their review and used the bivariate random-effects model to pool estimates.
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Our findings indicate that LAMP is a useful diagnostic test with a high sensitivity, specificity, likelihood ratios and post-test probability. Given a pre-test probability of 20%, the post-test probability for a positive test results was 95% and post-test probability of negative test result was 1%. There are however some potential limitations of using LAMP assay as a diagnostic tool. The LAMP assay very specifically detects the tcdA gene encoding the toxin and not the toxin itself. Therefore, patients with asymptomatic colonization with C. difficile can be misdiagnosed as true positives if inappropriate testing is performed. Additional studies are needed to better understand the role of LAMP for detection of asymptomatic colonization. Also, the test may remain positive for several weeks after the resolution of clinical symptoms and should not be used as a test for cure. Lastly, while the majority of clinicians agree that asymptomatic carriers should not be treated; there is no consensus on whether infection control interventions should be directed at isolation of the asymptomatic carriers.
Strengths and limitations of the review
We used a comprehensive search strategy to identify all relevant studies. Our search involved five unique and large databases with no language restrictions. Also, there was relatively low likelihood of publication bias as assessed by Deek's method.
The present study has some limitations. First, the varied study designs and the substantial heterogeneity among the pooled estimates soften any conclusions drawn from our meta-analysis. To minimize this, only studies that used TC or CCNA as the reference standard were included and analysed separately. We anticipated some degree of heterogeneity across the studies and performed pre-specified subgroup analyses (CDI prevalence and sample size) to reduce potential heterogeneity. None of the study characteristics however, were responsible for the majority of this heterogeneity. It is possible that hidden, unrecorded differences may have contributed to the heterogeneity. Second, our meta-analysis could not adjust for differences in patient populations, study variables and institutional characteristics. For example, prescription of the test must be strictly limited to patients with diarrhoea to avoid detecting asymptomatic carriers. Unfortunately, most studies did not specify the exact criteria used to submit patient stool samples for testing and we do not know definitively whether all patients with symptomatic diarrhoea were having CDI.
Conclusions
LAMP assay appears to be a highly sensitive and specific method for the rapid diagnosis of CDI. However as a relatively newer assay, and considerable heterogeneity among studies, a cautious approach may be needed, with more large scale, well designed studies to assess its true potential.
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Reporting
The study was reported according to the PRISMA Guidelines.
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